Nucana Plc ADR (NCNA)

$0.11 -0.04 (-24.41%)
Market Cap 698,000.00
Revenue (ttm) 0.00
Net Income (ttm) -24.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 121,218,203
Avg Vol 161,420,703
Day's Range N/A - N/A
Shares Out 6.08M
Stochastic %K 48%
Beta 1.24
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
JoeyIsFrigginMean
JoeyIsFrigginMean Jun. 16 at 9:12 AM
$NCNA Wake me up when we get to $0.50 and then again at $1.00. 2 cents does not get me hard..
0 · Reply
Jamedia66
Jamedia66 Jun. 16 at 8:59 AM
$NCNA and $PLRZ both very bullish
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:52 AM
$NCNA $PFE Bullish AF!!!!🐂🚀
0 · Reply
thelovestock
thelovestock Jun. 16 at 8:51 AM
$NCNA close to 30 million traded in the first hour
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:45 AM
$NCNA .50 Today 😊🐂🚀
0 · Reply
TraderNice
TraderNice Jun. 16 at 8:41 AM
$CEAD $NCNA $NVVE launch of a new crypto site? Did not hear about this? The price has risen sharply today
0 · Reply
Tradingistheway
Tradingistheway Jun. 16 at 8:40 AM
$NCNA complete 0
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 8:40 AM
Pre Market Top Gainers PT2 $KWM $RGC $SBET $NCNA $FTEL
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:36 AM
$NCNA bout to pull a $SNDL type of run like they did in 2021 wow!!!!😊 Bullish 🐂🚀
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:33 AM
$NCNA $PFE they running higher early!!!😊
0 · Reply
Latest News on NCNA
NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Jun 2, 2025, 4:01 PM EDT - 13 days ago

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mar 20, 2025, 4:01 PM EDT - 3 months ago

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Feb 10, 2025, 7:00 AM EST - 4 months ago

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 25, 2024, 7:00 AM EST - 7 months ago

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Nov 11, 2024, 7:00 AM EST - 7 months ago

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 9 months ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

Sep 25, 2024, 4:01 PM EDT - 9 months ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Sep 14, 2024, 3:01 AM EDT - 9 months ago

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

Aug 29, 2024, 4:01 PM EDT - 10 months ago

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 15, 2024, 4:01 PM EDT - 10 months ago

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:36 AM EDT - 1 year ago

NuCana to Present at the Jefferies Global Healthcare Conference

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

May 21, 2024, 8:00 AM EDT - 1 year ago

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

May 16, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 1, 2024, 4:01 PM EDT - 1 year ago

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

Apr 9, 2024, 4:30 PM EDT - 1 year ago

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

NuCana Announces Plan to Implement ADS Ratio Change

Mar 27, 2024, 4:30 PM EDT - 1 year ago

NuCana Announces Plan to Implement ADS Ratio Change

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

Feb 27, 2024, 8:00 AM EST - 1 year ago

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

NuCana: Potential Turnaround In 2024 But Risky

Jan 3, 2024, 2:39 AM EST - 1 year ago

NuCana: Potential Turnaround In 2024 But Risky

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 16, 2023, 4:01 PM EST - 1 year ago

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 1 year ago

NuCana Announces Listing Transfer to Nasdaq Capital Market

NuCana to Present at the Jefferies London Healthcare Conference

Nov 8, 2023, 4:01 PM EST - 1 year ago

NuCana to Present at the Jefferies London Healthcare Conference

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

Nov 1, 2023, 4:01 PM EDT - 1 year ago

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 16, 2023, 7:00 AM EDT - 1 year ago

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 13, 2023, 12:30 PM EDT - 1 year ago

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Sep 18, 2023, 8:00 AM EDT - 1 year ago

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 16, 2023, 4:01 PM EDT - 1 year ago

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 2 years ago

NuCana to Present at the Jefferies Healthcare Conference

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

May 17, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 2 years ago

NuCana Announces Receipt of Nasdaq Notice

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

Apr 14, 2023, 8:00 AM EDT - 2 years ago

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Apr 4, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

Mar 24, 2023, 4:30 PM EDT - 2 years ago

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 2 years ago

NuCana to Participate in Two Upcoming Investor Conferences

NuCana: Pipeline And Major Gilead Litigation Progressing Nicely

Jan 8, 2023, 4:30 AM EST - 2 years ago

NuCana: Pipeline And Major Gilead Litigation Progressing Nicely

NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Receipt of NASDAQ Notice

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 16, 2022, 4:01 PM EST - 2 years ago

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

Oct 26, 2022, 7:00 AM EDT - 2 years ago

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

NuCana: An Intriguing 'Sum Of The Parts' Story

Sep 22, 2022, 3:40 PM EDT - 2 years ago

NuCana: An Intriguing 'Sum Of The Parts' Story

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Sep 12, 2022, 10:45 AM EDT - 2 years ago

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

Sep 6, 2022, 8:00 AM EDT - 3 years ago

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

NuCana to Participate in Citi's 17th Annual BioPharma Conference

Aug 31, 2022, 8:00 AM EDT - 3 years ago

NuCana to Participate in Citi's 17th Annual BioPharma Conference

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 17, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead

Jul 13, 2022, 6:00 AM EDT - 3 years ago

NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead

Why NuCana Shares Are Rising Today?

Jul 11, 2022, 1:52 PM EDT - 3 years ago

Why NuCana Shares Are Rising Today?

German Court Rules that Gilead's Sofosbuvir Infringes NuCana's ‘190 Patent

Jul 11, 2022, 8:00 AM EDT - 3 years ago

German Court Rules that Gilead's Sofosbuvir Infringes NuCana's ‘190 Patent

NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress

Jun 10, 2022, 7:00 AM EDT - 3 years ago

NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress

NuCana Reports First Quarter 2022 Financial Results and Provides Business Update

Jun 2, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports First Quarter 2022 Financial Results and Provides Business Update

NuCana to Participate in the 2022 Jefferies Healthcare Conference

Jun 1, 2022, 4:01 PM EDT - 3 years ago

NuCana to Participate in the 2022 Jefferies Healthcare Conference

NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update

Apr 27, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update

JoeyIsFrigginMean
JoeyIsFrigginMean Jun. 16 at 9:12 AM
$NCNA Wake me up when we get to $0.50 and then again at $1.00. 2 cents does not get me hard..
0 · Reply
Jamedia66
Jamedia66 Jun. 16 at 8:59 AM
$NCNA and $PLRZ both very bullish
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:52 AM
$NCNA $PFE Bullish AF!!!!🐂🚀
0 · Reply
thelovestock
thelovestock Jun. 16 at 8:51 AM
$NCNA close to 30 million traded in the first hour
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:45 AM
$NCNA .50 Today 😊🐂🚀
0 · Reply
TraderNice
TraderNice Jun. 16 at 8:41 AM
$CEAD $NCNA $NVVE launch of a new crypto site? Did not hear about this? The price has risen sharply today
0 · Reply
Tradingistheway
Tradingistheway Jun. 16 at 8:40 AM
$NCNA complete 0
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 8:40 AM
Pre Market Top Gainers PT2 $KWM $RGC $SBET $NCNA $FTEL
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:36 AM
$NCNA bout to pull a $SNDL type of run like they did in 2021 wow!!!!😊 Bullish 🐂🚀
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:33 AM
$NCNA $PFE they running higher early!!!😊
0 · Reply
thelovestock
thelovestock Jun. 16 at 8:32 AM
$NCNA good volume so far keep it up let go high today
0 · Reply
Thamer_999m
Thamer_999m Jun. 16 at 8:29 AM
$NCNA Hold you haven't seen anything yet!
0 · Reply
ThrawnVestor
ThrawnVestor Jun. 16 at 8:29 AM
$NCNA just shows that @Tradingistheway doesn’t have a clue and you shouldn’t make your decisions based on anything he says. Silly bear
1 · Reply
hoonyinvests
hoonyinvests Jun. 16 at 8:27 AM
$NCNA oh we are so back
0 · Reply
JeanBets
JeanBets Jun. 16 at 8:26 AM
$NCNA 🦍🦍⭐️💰
0 · Reply
alandjoyce
alandjoyce Jun. 16 at 8:25 AM
$NCNA I know this 1st pre round is usually a quickie in and out. But hopefully it's a good indicator for the day.
0 · Reply
Tradingistheway
Tradingistheway Jun. 16 at 8:25 AM
$NCNA $NCNA Looks Weak. 😔👎👎👎
0 · Reply
Godwins26
Godwins26 Jun. 16 at 8:24 AM
$NCNA Wow yall we bout to go to $1 Let's Go!!!
0 · Reply
JOHNBOY2021
JOHNBOY2021 Jun. 16 at 8:19 AM
$NCNA Looks Strong. 😃👍👍👍
0 · Reply
Tradingistheway
Tradingistheway Jun. 16 at 8:17 AM
$NCNA people selling fast here everyone is leaving
0 · Reply
Thamer_999m
Thamer_999m Jun. 16 at 8:17 AM
$NCNA Here we go people
0 · Reply
Tradingistheway
Tradingistheway Jun. 16 at 8:17 AM
$NCNA good you left
0 · Reply